AMERICAN VANGUARD CORP

Regulatory Filings • Jul 31, 2002

8-K 1 a83209e8vk.htm FORM 8-K DATED JULY 29, 2002 American Vanguard Corporation Form 8-K PAGEBREAK

Table of Contents

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934

DATE OF REPORT — July 29, 2002

AMERICAN VANGUARD CORPORATION

(Exact name of registrant as specified in its charter)

Delaware (State of incorporation) 0-6354 (Commission File No.) 95-2588080 (IRS Employer No.)

4695 MacArthur Court, Newport Beach, California (Address of principal executive offices) 92660 (Zip Code)

(949) 260-1200 (Registrant’s telephone number, including area code)

PAGEBREAK

TOC

TABLE OF CONTENTS

Item 7. Exhibits.
SIGNATURES
EXHIBIT INDEX
EXHIBIT 99.6

/TOC

Table of Contents

link2 "Item 5. Other Events."

Item 5. Other Events.

On July 23, 2002, American Vanguard Corporation issued the press release attached hereto as Exhibit 99.6. The release announced that Amvac Chemical Corporation, a wholly-owned subsidiary of American Vanguard Corporation, has acquired from Syngenta Crop Protection, Inc., certain assets associated with the Ambush 25WP insecticide business, all as more particularly described in Exhibit 99.6. link2 "Item 7. Exhibits."

Item 7. Exhibits.

99.6 Press release issued July 23, 2002.

2 PAGEBREAK

Table of Contents

link1 "SIGNATURES"

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

/s/ J. A. Barry
J. A. Barry Senior Vice President
Chief Financial Officer

3 PAGEBREAK

Table of Contents

link1 "EXHIBIT INDEX"

EXHIBIT INDEX

EXHIBIT
NUMBER	DESCRIPTION
99.6	Press Release issued July 23, 2002.

4